TG THERAPEUTICS ($TGTX) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of $0.17 per share, missing estimates of $0.30 by $0.13. The company also reported revenue of $204,920,000, beating estimates of $200,750,575 by $4,169,425.
You can see Quiver Quantitative's $TGTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
TG THERAPEUTICS Insider Trading Activity
TG THERAPEUTICS insiders have traded $TGTX stock on the open market 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $TGTX stock by insiders over the last 6 months:
- YANN ECHELARD sold 5,000 shares for an estimated $162,850
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
TG THERAPEUTICS Hedge Fund Activity
We have seen 180 institutional investors add shares of TG THERAPEUTICS stock to their portfolio, and 173 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CLEARBRIDGE INVESTMENTS, LLC removed 1,196,442 shares (-25.8%) from their portfolio in Q4 2025, for an estimated $35,665,936
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 741,518 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $22,104,651
- SOLEUS CAPITAL MANAGEMENT, L.P. removed 705,419 shares (-18.3%) from their portfolio in Q4 2025, for an estimated $21,028,540
- BNP PARIBAS FINANCIAL MARKETS added 612,189 shares (+856.6%) to their portfolio in Q4 2025, for an estimated $18,249,354
- JUMP FINANCIAL, LLC removed 595,356 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $17,747,562
- BLACKROCK, INC. added 548,037 shares (+2.6%) to their portfolio in Q4 2025, for an estimated $16,336,982
- INVESCO LTD. added 515,481 shares (+47.1%) to their portfolio in Q4 2025, for an estimated $15,366,488
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
TG THERAPEUTICS Price Targets
Multiple analysts have issued price targets for $TGTX recently. We have seen 2 analysts offer price targets for $TGTX in the last 6 months, with a median target of $42.5.
Here are some recent targets:
- Brian Cheng from JP Morgan set a target price of $46.0 on 02/02/2026
- Corinne Johnson from Goldman Sachs set a target price of $39.0 on 01/15/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
